FDA Approves New 2-Gram Presentation of Fibryga®, Enhancing Convenience and Precision in Treating Acquired Fibrinogen Deficiency

Octapharma USA, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new 2-gram presentation ...
Business Wire

Lyophilized Drugs, Reconstitution Devices and Injection Market Report 2024 - The Importance of Technology and Regulatory Factors on Commercialization and Market Access ...

DUBLIN--(BUSINESS WIRE)--The "Lyophilized Drugs, Reconstitution Devices and Injection Markets: Products, Markets, Therapeutics, Strategies & Forecasts" report has been added to ...
News Medical

PBD Biotech’s new lyophilized PCR reaction bead offers easy ambient shipping, extends global reach of active TB test

Tuberculosis testing and treatment needs to happen close to the point of infection. PBD Biotech has developed a lyophilized PCR reaction bead for its Actiphage ® blood test for active TB. This enables ...
News Medical

Introducing Fit-for-Purpose Lyophilized PCR Assays

Simplify and accelerate the creation of your lyophilized amplification assay to expedite the development of your point-of-care application. Promega has dedicated time to perfecting reagent ...

FDA Approves New 2-Gram Presentation of Fibryga(R), Enhancing Convenience and Precision in Treating Acquired Fibrinogen Deficiency

Fibryga (R) is now approved in the U.S. for fibrinogen supplementation in both congenital and acquired fibrinogen deficiency, and is available in 1-gram and 2-gram kits, each with the nextaro (R) ...